Last night I reached an artificial milestone. Not an important one, but maybe of interest to some people. 10 days ago I refilled my pump with Fiasp insulin, and ever since then it’s been close to my skin under my clothes. As can be seen in my Nightscout site’s display, the Insulin Age is 9d24h (10 …
Lantus is a long-acting basal insulin which has been around since 2000. That’s about to change, but don’t panic. Essentially it’s just a name change. History Lantus is a U100 form of insulin glargine, made by Sanofi. Its patent protection eventually ran out, so new versions started appearing from other companies. Lilly (who also make Humalog) …
Fiasp insulin became available on the Australian PBS in June this year. Based on feedback from users overseas, I was prepared to encounter issues with trying to use it. I last wrote about my use of it in “Fiaspro” which seemed to be going fairly well. This article is a followup to that. Fiaspro I ended …
In the October update to the Australian PBS (Pharmaceutical Benefits Scheme), another insulin arrived today. Well, sort of. The addition is Semglee, which is a “biosimilar equivalent” to Lantus. Like Lantus it’s insulin glargine. Lantus is one of the commonly-used long-acting (or “basal”) insulin used for daily injections. It’s been around for years (I used …
There still seems to be some confusion in the community about whether the new Fiasp insulin should be used in a pump. Also confusion amongst the pump sales/support staff! The regulatory position is that while in the USA it is not approved for use in a pump, it is approved in both Australia and Europe. …
As I’ve previously written, the “ultra-fast” insulin Fiasp from Novo was added to PBS’s schedule as of June 1 2019. But everyone was surprised when we found it was only going to be supplied in two forms: vial and pre-filled pen. Incidentally, a year ago I spelt out the common usage of terms such as “vial”, “pen …